Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract

Kondo, Yuji; Yoshida, Haruhiko; Shiina, Shuichiro; Tateishi, Ryosuke; Teratani, Takuma; Omata, Masao

doi:10.1002/bjs.5374

Cited by 127 publications

(103 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, physiological saline is often injected around the lesion area to improve resolution to visualise this kind of special nodules (Kondo et al, 2008). However, artificial abdominal effusion can help determine the tuberculum close to the gastrointestine (Kondo et al, 2006). Therefore, the proposed methods can strengthen and enhance the adaptation of CEUS.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous Radiofrequency Ablation Guided by Contrast-enhanced Ultrasound in Treatment of Metastatic Hepatocellular Carcinoma after Liver Transplantation

Dai

Zhao²,

Liu³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

This study evaluated the advantages and applications of contrast-enhanced ultrasound (CEUS)-supported percutaneous radiofrequency ablation (RFA) in the treatment of metastatic hepatocellular carcinoma after liver transplantation, based on clinical details. CEUS-supported percutaneous RFA was adopted to treat 12 patients with hepatic metastatic carcinomas after liver transplantation. The diameters of the metastatic carcinomas varied from 1 cm to 5 cm, and the foci were discovered after 3 months to 12 months. Each focus was diagnosed and localised by CEUS for RFA once or twice. Curative effects were evaluated by CEUS or contrast-enhanced CT after the treatment. The re-examination results at 2 weeks post-treatment showed that the foci of 11 patients were ablated completely, whereas one patient with the largest focus required retreatment by RFA because of a partial residue. No local recurrence was found one month later in the re-examination. CEUS-supported percutaneous RFA in the treatment of hepatic metastatic carcinoma after liver transplantation has the advantages of accurate localisation, good efficacy, easy operation, and minimal invasion without any complications. Therefore, it can be recommended as the preferred therapy for hepatic metastatic carcinoma after liver transplantation.

show abstract

Section: Discussionmentioning

confidence: 99%

Percutaneous Radiofrequency Ablation Guided by Contrast-enhanced Ultrasound in Treatment of Metastatic Hepatocellular Carcinoma after Liver Transplantation

Dai

Zhao²,

Liu³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…In a recent prospective non-randomized study Teratani et al have reported very low incidence of viable tumor (14 out of 2,350 lesions in 1,219 patients, 0.6%), and no difference in local tumor progression rate between nodules in high-risk locations versus those elsewhere [132]. This was attributed to the use of artificial pleural effusion technique, artificial ascites technique [133] and guide-needle method. Table IV shows the clinical studies [21,[97][98][99][101][102][103]105,107,108,[123][124][125][126][127] reporting outcomes after treatment strategies employing RFA for HCC.…”

Section: Radiofrequency Ablation (Rfa) For Hccmentioning

confidence: 98%

Liver tumor ablation: Percutaneous and open approaches

Padma

Martinie

Iannitti

2009

Journal of Surgical Oncology

View full text Add to dashboard Cite

The global incidence of liver cancer is greater than a million cases a year. Surgical resection where applicable is still the standard of care for these patients. Various liver-directed regional therapies have been developed in an effort to treat the vast majority of unresectable liver tumors. This article reviews the principles behind various ablation therapies currently available for malignant liver tumors and their outcomes.

show abstract

“…and most of the solution infused into the peritoneal cavity would disappear in 3 to 7 days in our experience. e. Artificial ascites technique can be used in the cases that hepatocellular carcinoma is located at ventral or dorsal side beneath the liver capsule in order to avoid the thermal effect to the abdominal wall or gastrointestinal tract (Kondo et al, 2006).…”

Section: Learning Of the Knack Of Artificial Ascites Proceduresmentioning

confidence: 99%

Radiofrequency Ablation for Hepatocellular Carcinoma at the Dome of the Liver: A Review

Mochizuki¹

2012

Hepatocellular Carcinoma - Clinical Research

View full text Add to dashboard Cite

Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract

Cited by 127 publications

References 21 publications

Percutaneous Radiofrequency Ablation Guided by Contrast-enhanced Ultrasound in Treatment of Metastatic Hepatocellular Carcinoma after Liver Transplantation

Percutaneous Radiofrequency Ablation Guided by Contrast-enhanced Ultrasound in Treatment of Metastatic Hepatocellular Carcinoma after Liver Transplantation

Liver tumor ablation: Percutaneous and open approaches

Radiofrequency Ablation for Hepatocellular Carcinoma at the Dome of the Liver: A Review

Contact Info

Product

Resources

About